GT200100063A - El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoariaen mamiferos - Google Patents
El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoariaen mamiferosInfo
- Publication number
- GT200100063A GT200100063A GT200100063A GT200100063A GT200100063A GT 200100063 A GT200100063 A GT 200100063A GT 200100063 A GT200100063 A GT 200100063A GT 200100063 A GT200100063 A GT 200100063A GT 200100063 A GT200100063 A GT 200100063A
- Authority
- GT
- Guatemala
- Prior art keywords
- mammals
- protozoary
- treat
- azalides
- antibiotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE DESCRIBEN METODOS PARA TRATAR O PREVENIR INFECCIONES BACTERIANAS O PROTOZOARIAS EN MAMIFEROS POR ADMINISTRACION DE UNA UNICA DOSIS DE UNA COMPOSICION DE ANTIBIOTICO QUE COMPRENDE UNA MEZCLA DE ISOMEROS DE AZALIDOS Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. SE DESCRIBEN TAMBIEN METODOS PARA AUMENTAR LA TOLERANCIA DE SITIOS DE INYECCION, AGUDA O CRONICA, EN MAMIFEROS POR ADMINISTRACION DE UNA UNICA DOSIS DE COMPOSICIONES ANTIBIOTICAS QUE COMPRENDEN UNA MEZCLA DE ISOMEROS AZALIDOS Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. SE DESCRIBE TAMBIEN UNA COMBINACION QUE COMPRENDE: UNA COMPOSICION ANTIBIOTICA QUE COMPRENDE UNA MEZCLA DE ISOMEROS DE AZALIDOS, UN VEHICULO FARMACEUTICAMENTE ACEPTABLE, E INTRUCCIONES PARA EL USO EN UNA ADMINISTRACION DE UNA SOLA DOSIS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19996100P | 2000-04-27 | 2000-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200100063A true GT200100063A (es) | 2002-02-18 |
Family
ID=22739732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200100063A GT200100063A (es) | 2000-04-27 | 2001-04-20 | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoariaen mamiferos |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20020019353A1 (es) |
| EP (1) | EP1276747A1 (es) |
| JP (1) | JP2004516233A (es) |
| KR (1) | KR20030031479A (es) |
| CN (1) | CN1227258C (es) |
| AP (1) | AP2002002652A0 (es) |
| AR (1) | AR028041A1 (es) |
| AU (1) | AU4269301A (es) |
| BG (1) | BG107168A (es) |
| BR (1) | BR0110382A (es) |
| CA (1) | CA2407448A1 (es) |
| CZ (1) | CZ20023409A3 (es) |
| EA (1) | EA200200995A1 (es) |
| GT (1) | GT200100063A (es) |
| HU (1) | HUP0300585A3 (es) |
| IL (1) | IL152421A0 (es) |
| IS (1) | IS6559A (es) |
| MA (1) | MA26896A1 (es) |
| MX (1) | MXPA02010586A (es) |
| NO (1) | NO20025134L (es) |
| OA (1) | OA12257A (es) |
| PA (1) | PA8515601A1 (es) |
| PE (1) | PE20011188A1 (es) |
| PL (1) | PL359861A1 (es) |
| SK (1) | SK14882002A3 (es) |
| TN (1) | TNSN01063A1 (es) |
| UY (1) | UY26678A1 (es) |
| WO (1) | WO2001081358A1 (es) |
| YU (1) | YU78702A (es) |
| ZA (1) | ZA200208603B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003040782A (ja) * | 2001-05-31 | 2003-02-13 | Pfizer Prod Inc | アザリド抗生物質組成物 |
| AU2002317415A1 (en) * | 2001-08-01 | 2003-02-17 | Pfizer Products Inc. | Azalide antibiotic compositions |
| US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| WO2009006466A1 (en) * | 2007-07-02 | 2009-01-08 | Novus International Inc. | Feeding regime for prevention of porcine enteropathic conditions |
| WO2009117036A2 (en) * | 2007-12-21 | 2009-09-24 | Massachusetts Institute Of Technology | Bioactive molecules from co-cultivation of microbes |
| CA2877884C (en) * | 2012-06-27 | 2022-09-06 | Kemin Industries, Inc. | Animal feed compositions for controlling coccidiosis in animals |
| US10568923B2 (en) * | 2012-06-27 | 2020-02-25 | Kemin Industries, Inc. | Plant parts and extracts having anticoccidial activity |
| EP3554254A1 (en) | 2016-12-15 | 2019-10-23 | Société des Produits Nestlé S.A. | Compositions and methods that modulate bacteria in a companion animal |
| CN106905396A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 富马酸替米考星复盐的制备方法 |
| CN106905395A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 丁二酸替米考星复盐的制备方法 |
| CN106749458A (zh) * | 2017-02-21 | 2017-05-31 | 西南大学 | 苹果酸替米考星复盐的制备方法 |
| CA3054023A1 (en) * | 2017-02-22 | 2018-08-30 | Immune System Regulation Holding Ab | Novel immune stimulating macrolides |
| AU2019385333A1 (en) * | 2018-11-19 | 2021-07-01 | President And Fellows Of Harvard College | C10-alkylene substituted 13-membered macrolides and uses thereof |
| CN109535211B (zh) * | 2018-12-19 | 2020-05-08 | 江苏威凌生化科技有限公司 | 一种合成纯化泰拉霉素杂质c的方法 |
| WO2023038852A1 (en) * | 2021-09-07 | 2023-03-16 | Zoetis Services Llc | Immunomodulating azalides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2001
- 2001-03-26 JP JP2001578446A patent/JP2004516233A/ja not_active Withdrawn
- 2001-03-26 CN CNB018086306A patent/CN1227258C/zh not_active Expired - Fee Related
- 2001-03-26 SK SK1488-2002A patent/SK14882002A3/sk unknown
- 2001-03-26 HU HU0300585A patent/HUP0300585A3/hu unknown
- 2001-03-26 AU AU42693/01A patent/AU4269301A/en not_active Abandoned
- 2001-03-26 EP EP01915612A patent/EP1276747A1/en not_active Withdrawn
- 2001-03-26 PL PL35986101A patent/PL359861A1/xx not_active Application Discontinuation
- 2001-03-26 MX MXPA02010586A patent/MXPA02010586A/es unknown
- 2001-03-26 OA OA1200200332A patent/OA12257A/en unknown
- 2001-03-26 AP APAP/P/2002/002652A patent/AP2002002652A0/en unknown
- 2001-03-26 CZ CZ20023409A patent/CZ20023409A3/cs unknown
- 2001-03-26 EA EA200200995A patent/EA200200995A1/ru unknown
- 2001-03-26 KR KR1020027014453A patent/KR20030031479A/ko not_active Application Discontinuation
- 2001-03-26 YU YU78702A patent/YU78702A/sh unknown
- 2001-03-26 IL IL15242101A patent/IL152421A0/xx unknown
- 2001-03-26 BR BR0110382-2A patent/BR0110382A/pt not_active IP Right Cessation
- 2001-03-26 WO PCT/IB2001/000519 patent/WO2001081358A1/en not_active Application Discontinuation
- 2001-03-26 CA CA002407448A patent/CA2407448A1/en not_active Abandoned
- 2001-04-10 US US09/829,672 patent/US20020019353A1/en not_active Abandoned
- 2001-04-17 PA PA20018515601A patent/PA8515601A1/es unknown
- 2001-04-20 GT GT200100063A patent/GT200100063A/es unknown
- 2001-04-24 UY UY26678A patent/UY26678A1/es not_active Application Discontinuation
- 2001-04-24 PE PE2001000364A patent/PE20011188A1/es not_active Application Discontinuation
- 2001-04-25 AR ARP010101943A patent/AR028041A1/es not_active Application Discontinuation
- 2001-04-26 TN TNTNSN01063A patent/TNSN01063A1/fr unknown
-
2002
- 2002-09-20 IS IS6559A patent/IS6559A/is unknown
- 2002-10-03 BG BG107168A patent/BG107168A/bg unknown
- 2002-10-18 MA MA26874A patent/MA26896A1/fr unknown
- 2002-10-24 ZA ZA200208603A patent/ZA200208603B/xx unknown
- 2002-10-25 NO NO20025134A patent/NO20025134L/no not_active Application Discontinuation
-
2003
- 2003-12-23 US US10/745,748 patent/US20040235759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU4269301A (en) | 2001-11-07 |
| CN1227258C (zh) | 2005-11-16 |
| BG107168A (bg) | 2003-07-31 |
| US20040235759A1 (en) | 2004-11-25 |
| AR028041A1 (es) | 2003-04-23 |
| JP2004516233A (ja) | 2004-06-03 |
| ZA200208603B (en) | 2003-10-24 |
| EP1276747A1 (en) | 2003-01-22 |
| AP2002002652A0 (en) | 2002-12-31 |
| UY26678A1 (es) | 2001-12-28 |
| NO20025134L (no) | 2002-12-19 |
| TNSN01063A1 (fr) | 2005-11-10 |
| EA200200995A1 (ru) | 2003-04-24 |
| NO20025134D0 (no) | 2002-10-25 |
| CA2407448A1 (en) | 2001-11-01 |
| PL359861A1 (en) | 2004-09-06 |
| PE20011188A1 (es) | 2001-11-24 |
| IS6559A (is) | 2002-09-20 |
| BR0110382A (pt) | 2003-06-24 |
| US20020019353A1 (en) | 2002-02-14 |
| YU78702A (sh) | 2005-11-28 |
| HUP0300585A2 (hu) | 2003-06-28 |
| OA12257A (en) | 2003-11-06 |
| MA26896A1 (fr) | 2004-12-20 |
| CN1429232A (zh) | 2003-07-09 |
| KR20030031479A (ko) | 2003-04-21 |
| CZ20023409A3 (cs) | 2004-01-14 |
| WO2001081358A1 (en) | 2001-11-01 |
| PA8515601A1 (es) | 2002-07-30 |
| HUP0300585A3 (en) | 2003-09-29 |
| SK14882002A3 (en) | 2004-11-03 |
| MXPA02010586A (es) | 2003-03-10 |
| IL152421A0 (en) | 2003-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200100063A (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoariaen mamiferos | |
| BRPI0518282A2 (pt) | uso de uma quantidade terapeuticamente ou profilaticamente efetiva de um composto imunomodulatàrio | |
| BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
| BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
| ECSP056159A (es) | Composición de fármaco conjugado | |
| BRPI0518255A2 (pt) | mÉtodos de tratamento ou prevenÇço de uma lesço do sistema nervoso central, para reduzir ou evitar um efeito adverso, e composiÇço farmacÊutica | |
| BRPI0612669B8 (pt) | composição imunogênica, vacina, composição, e composição liofilizada | |
| CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
| CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
| NO20000314L (no) | Farmasøytiske sammensetninger som inneholder lysostafin alene eller i kombinasjon med et antibiotika for behandling av stafylokokkinfeksjoner | |
| BR0305628A (pt) | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso | |
| RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
| MXPA02012611A (es) | Composicion anestesica, acuosa, clara. | |
| ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
| BR0008468A (pt) | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos | |
| BRPI0614197B8 (pt) | composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição | |
| CO5570661A2 (es) | Combinaciones que comprenden inhibidores de cox-2 y aspirina | |
| TNSN07285A1 (en) | Anthelmintic composition | |
| DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
| ATE378070T1 (de) | Zusammensetzung mit fulvestrant | |
| CO5560585A2 (es) | Formulacion farmaceutica para administracion intramuscular de fulvestrant | |
| CL2004000765A1 (es) | Composicion farmaceutica intranasal que comprende un compuesto derivado de 8,9-dioxo-2,6-diazabiciclo. | |
| AR023781A1 (es) | Formulaciones farmaceuticas | |
| AR043016A2 (es) | Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene |